Citations (8)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Bernhard Resch. (2008) Palivizumab in preventing respiratory syncytial virus-related hospitalization in high-risk infants. Expert Review of Pharmacoeconomics & Outcomes Research 8:6, pages 529-538.
Read now
Read now
Articles from other publishers (7)
Mary T. Caserta, Sean T. O’Leary, Flor M. Munoz, Shawn L. Ralston, Sean T. O’Leary, James D. Campbell, Monica I. Ardura, Ritu Banerjee, Kristina A. Bryant, Mary T. Caserta, Jeffrey S. Gerber, Chandy C. John, Athena P. Kourtis, Angela Myers, Pia Pannaraj, Adam J. Ratner, José R. Romero, Samir S. Shah, Kenneth M. Zangwill, Yvonne A. Maldonado, Flor M. Munoz, Shawn L. Ralston, David W. Kimberlin, Elizabeth D. Barnett, Ruth Lynfield, Mark H. Sawyer, Henry H. Bernstein, Karen M. Farizo, Lisa M. Kafer, David Kim, Eduardo López Medina, Denee Moore, Lakshmi Panagiotakopoulos, Laura Sauvé, Jeffrey R. Starke, Jennifer Thompson, Kay M. Tomashek, Melinda Wharton, Charles R. WoodsJr.Jr. & Jennifer M. Frantz. (2023) Palivizumab Prophylaxis in Infants and Young Children at Increased Risk of Hospitalization for Respiratory Syncytial Virus Infection. Pediatrics.
Crossref
Crossref
Michael T. Brady, Carrie L. Byington, H. Dele Davies, Kathryn M. Edwards, Mary Anne Jackson, Yvonne A. Maldonado, Dennis L. Murray, Walter A. Orenstein, Mobeen H. Rathore, Mark H. Sawyer, Gordon E. Schutze, Rodney E. Willoughby, Theoklis E. Zaoutis, Shawn L. Ralston, Allan S. Lieberthal, H. Cody Meissner, Brian K. Alverson, Jill E. Baley, Anne M. Gadomski, David W. Johnson, Michael J. Light, Nizar F. Maraqa, Eneida A. Mendonca, Kieran J. Phelan, Joseph J. Zorc, Danette Stanko-Lopp & Sinsi Hernández-Cancio. (2014) Updated Guidance for Palivizumab Prophylaxis Among Infants and Young Children at Increased Risk of Hospitalization for Respiratory Syncytial Virus Infection. Pediatrics 134:2, pages e620-e638.
Crossref
Crossref
Andrew HiattNatasha BohorovaOgnian BohorovCharles GoodmanDo KimMichael H. PaulyJesus VelascoKevin J. WhaleyPedro A. Piedra, Brian E. Gilbert & Larry Zeitlin. (2014) Glycan variants of a respiratory syncytial virus antibody with enhanced effector function and in vivo efficacy. Proceedings of the National Academy of Sciences 111:16, pages 5992-5997.
Crossref
Crossref
Tea Andabaka, Jason W Nickerson, Maria Ximena Rojas-Reyes, Juan David Rueda, Vesna Bacic Vrca & Bruno Barsic. (2013) Monoclonal antibody for reducing the risk of respiratory syncytial virus infection in children. Evidence-Based Child Health: A Cochrane Review Journal 8:6, pages 2243-2376.
Crossref
Crossref
Tea Andabaka, Jason W Nickerson, Maria Ximena Rojas-Reyes, Juan David Rueda, Vesna Bacic Vrca & Bruno Barsic. (2013) Monoclonal antibody for reducing the risk of respiratory syncytial virus infection in children. Cochrane Database of Systematic Reviews.
Crossref
Crossref
Bernhard Resch, Constanze Sommer, Mark J. C. Nuijten, Susanne Seidinger, Evelyn Walter, Vera Schoellbauer & Wilhelm D. Mueller. (2012) Cost-effectiveness of Palivizumab for Respiratory Syncytial Virus Infection in High-risk Children, Based on Long-term Epidemiologic Data From Austria. Pediatric Infectious Disease Journal 31:1, pages e1-e8.
Crossref
Crossref
J. González de Dios & C. Ochoa Sangrador. (2010) Conferencia de Consenso sobre bronquiolitis aguda (I): metodología y recomendaciones. Anales de Pediatría 72:3, pages 221.e1-221.e33.
Crossref
Crossref